Key points are not available for this paper at this time.
Post-operative breast cancer patients undergoing chemotherapy frequently experience concurrent upper limb dysfunction and chemotherapy-related cognitive impairment, creating a synergistic burden that complicates rehabilitation. Existing interventions often target these issues in isolation. Baduanjin, a traditional Chinese mind-body exercise, integrates physical movement with cognitive engagement, making it a promising candidate for addressing both domains simultaneously. However, robust evidence from randomized controlled trials (RCTs) was lacking. This RCT aimed to evaluate the effects of Baduanjin on both cognitive performance and upper limb function in this population. A two-arm, randomized controlled trial was conducted. Seventy women diagnosed with breast cancer and scheduled for chemotherapy were randomly assigned to either a 12-week supervised Baduanjin exercise group or a control group receiving usual care. Subjective cognitive function was assessed using the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog). The neuropsychological test battery included the Auditory Verbal Learning Test (AVLT), the Trail Making Test (TMT), and the Digit Symbol Substitution Test (DSST). Upper limb function was assessed using the Constant-Murley Score (CMS). All assessments were performed at baseline (T0), Week 4 (T1), Week 8 (T2), and Week 12 (T3). Compared to the control group, the Baduanjin group demonstrated significant improvements in total FACT-Cog scores ( F =17.710, p < 0.001), perceived cognitive impairments ( F =20.085, p < 0.001), and perceived cognitive abilities ( F =5.116, p =0.027). A statistically significant group effect was observed for AVLT6 ( F =13.862, p < 0.001). In addition, significant differences were observed between the two groups in shoulder function ( p =0.004, 95% CI: 1.09, 5.59) and ROM ( p =0.002, 95% CI: 0.87, 3.98). A 12-week Baduanjin exercise intervention significantly improved subjective cognitive complaints and shoulder function in breast cancer patients undergoing post-operative chemotherapy. The findings support Baduanjin as a safe, feasible, and beneficial adjunct therapy that can concurrently address two prevalent and distressing sequelae of breast cancer treatment. • This study is the first to investigate Baduanjin, a traditional Chinese mind-body exercise, in simultaneously addressing chemotherapy-related cognitive impairment (CRCI) and upper limb dysfunction in postoperative breast cancer patients undergoing chemotherapy, an area with limited prior research. • Utilizes neuropsychological test to quantitatively evaluate cognitive improvements, overcoming reliance on subjective patient-reported outcomes common in existing mind-body intervention studies. • Demonstrates that Baduanjin may improve subjective cognitive complaints and shoulder function in patients undergoing chemotherapy after breast cancer surgery. • Demonstrates a high compliance rate and no adverse events, supporting the feasibility of Baduanjin as a low-cost adjuvant therapy in oncology rehabilitation settings.
Wei et al. (Wed,) studied this question.